Literature DB >> 17506138

Treatment of cutaneous and mucosal telangiectases in hereditary hemorrhagic telangiectasia: Report of three cases.

Beatriz Fernández-Jorge1, Jesús Del Pozo Losada, Sabela Paradela, Covadonga Martínez-González, Edvardo Fonseca.   

Abstract

INTRODUCTION: Hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease is an autosomal dominant disorder characterized by epistaxis, mucocutaneous telangiectases and visceral arteriovenous malformations. Cutaneous telangiectases are the most obvious sign of this disorder and are not a merely cosmetic problem owing to their risk for bleeding, which may constitute an authentic matter of concern to these patients.
METHODS: Three patients with type-II HHT disease who presented cutaneous and labial lesions were treated with an intense pulsed light (IPL) system associated with a long-pulsed Nd:YAG laser (Photoderm-Vasculight, Lumenis). Labial lesions were treated with the IPL system and cutaneous lesions were treated with the IPL system and the long-pulsed Nd:YAG laser. All treatments were accomplished on an outpatient basis, without anesthesia.
RESULTS: All three patients experienced a reduction in the frequency and severity of bleeding episodes and a great cosmetic improvement, with total lesion clearance. Side effects, such as purpura, hypopigmentation, hyperpigmentation or textural changes, were not observed. Recurrences were not detected after a maximum period of 24 months of follow-up.
CONCLUSION: The combination of an IPL system and a long-pulsed Nd:YAG laser is efficient and safe for the treatment of cutaneous and labial telangiectases in patients with HHT disease and constitutes an important tool in improving their quality of life.

Entities:  

Mesh:

Year:  2007        PMID: 17506138     DOI: 10.1080/14764170601091687

Source DB:  PubMed          Journal:  J Cosmet Laser Ther        ISSN: 1476-4172            Impact factor:   2.247


  5 in total

1.  A case of hereditary hemorrhagic telangiectasia.

Authors:  Ha Eun Lee; Chan Sagong; Kwang Yeoll Yeo; Joo Yeon Ko; Joung Soo Kim; Hee Joon Yu
Journal:  Ann Dermatol       Date:  2009-05-31       Impact factor: 1.444

2.  Intensity-modulated radiotherapy for a rendu-osler-weber disease patient with recurrent severe epistaxis: a case report.

Authors:  Maximilian Niyazi; Marco-Domenico Caversaccio; Patrick Dubach; Andreas Geretschläger; Andreas Arnold; Claus Belka; Daniel M Aebersold; Norbert M Blumstein
Journal:  Case Rep Med       Date:  2010-03-28

3.  Treatment of the skin manifestations of hereditary hemorrhagic telangiectasia with pulsed dye laser.

Authors:  Shlomit Halachmi; Hadar Israeli; Dan Ben-Amitai; Moshe Lapidoth
Journal:  Lasers Med Sci       Date:  2013-05-17       Impact factor: 3.161

4.  Hereditary haemorrhagic telangiectasia: A case report.

Authors:  Asfandyar Mufti; Muskaan Sachdeva; Khalad Maliyar; Marissa Joseph
Journal:  SAGE Open Med Case Rep       Date:  2021-08-06

5.  Quantification metrics for telangiectasia using optical coherence tomography.

Authors:  Jillian L Cardinell; Joel M Ramjist; Chaoliang Chen; Weisong Shi; Nhu Q Nguyen; Tiffany Yeretsian; Matthew Choi; David Chen; Dewi S Clark; Anne Curtis; Helen Kim; Marie E Faughnan; Victor X D Yang
Journal:  Sci Rep       Date:  2022-02-02       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.